{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:44:55Z","timestamp":1776419095610,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["20-2(11)\/ASIP\/R&D\/HEC\/17000754(CAMB)\/55"],"award-info":[{"award-number":["20-2(11)\/ASIP\/R&D\/HEC\/17000754(CAMB)\/55"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05048-x","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:46:10Z","timestamp":1776372370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A report of novel inactivating missense mutations of BRCA1 detected in patients with acute myeloid leukemia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-6808","authenticated-orcid":false,"given":"Samina","family":"Ejaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anam","family":"Raashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqra","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagina","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryum","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas Nazir","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"18","key":"5048_CR1","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1101\/gad.284109.116","volume":"30","author":"D Hu","year":"2016","unstructured":"Hu D, Shilatifard A. Epigenetics of hematopoiesis and hematological malignancies. Genes Dev. 2016;30(18):2021\u201341.","journal-title":"Genes Dev"},{"key":"5048_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1376955","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yu S, Chen Y, Hu Z, Fan L, Liang G. The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment. Front Pharmacol. 2024. https:\/\/doi.org\/10.3389\/fphar.2024.1376955.","journal-title":"Front Pharmacol"},{"key":"5048_CR3","volume-title":"Lymphoma","author":"A Jamil","year":"2024","unstructured":"Jamil A, Mukkamalla SKR. Lymphoma. StatPearls: StatPearls Publishing; 2024."},{"issue":"1","key":"5048_CR4","first-page":"22","volume":"78","author":"M Ciesielska","year":"2024","unstructured":"Ciesielska M, Orzechowska B, Gamian A, Kazanowska B. Epidemiology of childhood acute leukemias. Adv Hyg Exp Med. 2024;78(1):22\u201336.","journal-title":"Adv Hyg Exp Med"},{"issue":"1","key":"5048_CR5","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"5048_CR6","unstructured":"Society LL. Facts and Statistics Overview. 2023. American Cancer Society\u2019s Cancer Facts & Figures 2024. https:\/\/www.lls.org\/facts-and-statistics\/facts-and-statistics-overview."},{"key":"5048_CR7","doi-asserted-by":"publisher","first-page":"1329529","DOI":"10.3389\/fpubh.2023.1329529","volume":"11","author":"P Chen","year":"2024","unstructured":"Chen P, Liu X, Zhao Y, Hu Y, Guo J, Wang H. Global, national, and regional burden of acute myeloid leukemia among 60\u201389 years-old individuals: insights from a study covering the period 1990 to 2019. Front Public Health. 2024;11:1329529.","journal-title":"Front Public Health"},{"key":"5048_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4644-6","volume":"18","author":"AC Shysh","year":"2018","unstructured":"Shysh AC, Nguyen LT, Guo M, Vaska M, Naugler C, Rashid-Kolvear F. The incidence of acute myeloid leukemia in Calgary, Alberta, Canada: a retrospective cohort study. BMC Public Health. 2018;18:1\u20135.","journal-title":"BMC Public Health"},{"issue":"6","key":"5048_CR9","first-page":"625","volume":"33","author":"A Ikram","year":"2023","unstructured":"Ikram A, Pervez S, Khadim MT, Sohaib M, Uddin H, Badar F, et al. National cancer registry of Pakistan: first comprehensive report of cancer statistics 2015\u20132019. J Coll Phys Surg Pak. 2023;33(6):625\u201332.","journal-title":"J Coll Phys Surg Pak"},{"issue":"4","key":"5048_CR10","first-page":"515","volume":"7","author":"G Ilhan","year":"2006","unstructured":"Ilhan G, Karakus S, Andic N. Risk factors and primary prevention of acute leukemia. Asian Pac J Cancer Prev. 2006;7(4):515\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"5048_CR11","first-page":"4684","volume":"16","author":"T Fang","year":"2024","unstructured":"Fang T, Zhang Z, Ren K, Zou L. Genetically determined telomere length as a risk factor for hematological malignancies: evidence from Mendelian randomization analysis. Aging. 2024;16(5):4684.","journal-title":"Aging"},{"issue":"4","key":"5048_CR12","first-page":"328","volume":"11","author":"FA Lagunas-Rangel","year":"2017","unstructured":"Lagunas-Rangel FA, Ch\u00e1vez-Valencia V, G\u00f3mez-Guijosa M, Cortes-Penagos C. Acute myeloid leukemia-genetic alterations and their clinical prognosis. Int J Hematol Oncol Stem Cell Res. 2017;11(4):328\u201339.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"5048_CR13","doi-asserted-by":"publisher","first-page":"100989","DOI":"10.1016\/j.neo.2024.100989","volume":"51","author":"H Ahmad","year":"2024","unstructured":"Ahmad H, Ali A, Ali R, Khalil AT, Khan I, Khan MM, et al. Preliminary insights on the mutational spectrum of BRCA1 and BRCA2 genes in Pakhtun ethnicity breast cancer patients from Khyber Pakhtunkhwa (KP), Pakistan. Neoplasia. 2024;51:100989.","journal-title":"Neoplasia"},{"key":"5048_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.813457","author":"X Fu","year":"2022","unstructured":"Fu X, Tan W, Song Q, Pei H, Li J. BRCA1 and breast cancer: molecular mechanisms and therapeutic strategies. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.813457.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5048_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2011","unstructured":"Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12(1):68\u201378.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"5048_CR16","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.7150\/jca.30410","volume":"10","author":"I Gorodetska","year":"2019","unstructured":"Gorodetska I, Kozeretska I, Dubrovska A. BRCA genes: the role in genome stability, cancer stemness and therapy resistance. J Cancer. 2019;10(9):2109\u201327.","journal-title":"J Cancer"},{"issue":"8","key":"5048_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1101\/gad.14.8.927","volume":"14","author":"Y Wang","year":"2000","unstructured":"Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 2000;14(8):927\u201339.","journal-title":"Genes Dev"},{"issue":"1","key":"5048_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41421-023-00590-8","volume":"9","author":"D Wu","year":"2023","unstructured":"Wu D, Huang H, Chen T, Gai X, Li Q, Wang C, et al. The BRCA1\/BARD1 complex recognizes pre-ribosomal RNA to facilitate homologous recombination. Cell Discov. 2023;9(1):99.","journal-title":"Cell Discov"},{"issue":"18","key":"5048_CR19","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1042\/BCJ20200864","volume":"478","author":"SR Witus","year":"2021","unstructured":"Witus SR, Stewart MD, Klevit RE. The BRCA1\/BARD1 ubiquitin ligase and its substrates. Biochem J. 2021;478(18):3467\u201383.","journal-title":"Biochem J"},{"key":"5048_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-1028-3-1","volume":"3","author":"W Wu","year":"2008","unstructured":"Wu W, Koike A, Takeshita T, Ohta T. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div. 2008;3:1.","journal-title":"Cell Div"},{"key":"5048_CR21","doi-asserted-by":"publisher","first-page":"796808","DOI":"10.6064\/2012\/796808","volume":"2012","author":"BR Henderson","year":"2012","unstructured":"Henderson BR. The BRCA1 breast cancer suppressor: regulation of transport, dynamics, and function at multiple subcellular locations. Scientifica. 2012;2012:796808.","journal-title":"Scientifica"},{"issue":"1","key":"5048_CR22","doi-asserted-by":"publisher","first-page":"e201204005","DOI":"10.5936\/csbj.201204005","volume":"1","author":"SL Clark","year":"2012","unstructured":"Clark SL, Rodriguez AM, Snyder RR, Hankins GD, Boehning D. Structure-function of the tumor suppressor BRCA1. Comput Struct Biotechnol J. 2012;1(1):e201204005.","journal-title":"Comput Struct Biotechnol J"},{"key":"5048_CR23","doi-asserted-by":"publisher","first-page":"114090","DOI":"10.1016\/j.biopha.2022.114090","volume":"158","author":"E Choi","year":"2023","unstructured":"Choi E, Mun G-I, Lee J, Lee H, Cho J, Lee Y-S. BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy. Biomed Pharmacother. 2023;158:114090.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5048_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2407-7-152","volume":"7","author":"B Friedenson","year":"2007","unstructured":"Friedenson B. The BRCA1\/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer. 2007;7(1):152.","journal-title":"BMC Cancer"},{"issue":"8","key":"5048_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/sj.bjc.6603392","volume":"95","author":"A Scardocci","year":"2006","unstructured":"Scardocci A, Guidi F, D\u2019Alo F, Gumiero D, Fabiani E, DiRuscio A, et al. Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia. Br J Cancer. 2006;95(8):1108\u201313.","journal-title":"Br J Cancer"},{"issue":"20","key":"5048_CR26","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1128\/MCB.20.20.7450-7459.2000","volume":"20","author":"P Arizti","year":"2000","unstructured":"Arizti P, Fang L, Park I, Yin Y, Solomon E, Ouchi T, et al. Tumor suppressor p53 is required to modulate BRCA1 expression. Mol Cell Biol. 2000;20(20):7450\u20139.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"5048_CR27","doi-asserted-by":"publisher","first-page":"0975","DOI":"10.21123\/bsj.2023.7981","volume":"21","author":"ZN Nasif","year":"2024","unstructured":"Nasif ZN. Comparative study of genomic DNA extraction protocols from whole blood for P53 gene polymorphism in persons with and without prostate cancer. Baghdad Sci J. 2024;21(3):0975.","journal-title":"Baghdad Sci J"},{"key":"5048_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/574398","author":"SC Tan","year":"2009","unstructured":"Tan SC, Yiap BC. DNA, RNA, and protein extraction: the past and the present. BioMed Res Int. 2009. https:\/\/doi.org\/10.1155\/2009\/574398.","journal-title":"BioMed Res Int"},{"key":"5048_CR29","unstructured":"Schiffer T. Molekulare Analyse des BRCA1-Gens in famili\u00e4ren und sporadischen Mammakarzinomen: D\u00fcsseldorf, Univ., Diss., 2003; 2002."},{"issue":"3","key":"5048_CR30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbadis.2014.12.001","volume":"1852","author":"I Faraoni","year":"2015","unstructured":"Faraoni I, Compagnone M, Lavorgna S, Angelini DF, Cencioni MT, Piras E, et al. BRCA1, PARP1 and \u03b3H2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib. Biochimica et Biophysica Acta (BBA) Mol Basis Dis. 2015;1852(3):462\u201372.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Dis"},{"issue":"2","key":"5048_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7150\/ijbs.14242","volume":"12","author":"T Masuda","year":"2016","unstructured":"Masuda T, Xu X, Dimitriadis EK, Lahusen T, Deng CX. \u201cDNA binding region\u201d of BRCA1 affects genetic stability through modulating the intra-S-phase checkpoint. Int J Biol Sci. 2016;12(2):133\u201343.","journal-title":"Int J Biol Sci"},{"issue":"17","key":"5048_CR32","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","volume":"106","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci. 2009;106(17):7155\u201360.","journal-title":"Proc Natl Acad Sci"},{"key":"5048_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/B978-0-12-374984-0.00171-6","volume-title":"BRCA1\/BRCA2. J Brenner\u2019s encyclopedia of genetics","author":"A Ashworth","year":"2013","unstructured":"Ashworth A. BRCA1\/BRCA2. J Brenner\u2019s encyclopedia of genetics. Amsterdam: Elsevier; 2013. p. 381\u20133."},{"issue":"3","key":"5048_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/ph17030333","volume":"17","author":"T Ismail","year":"2024","unstructured":"Ismail T, Alzneika S, Riguene E, Al-maraghi S, Alabdulrazzak A, Al-Khal N, et al. BRCA1 and its vulnerable C-terminal BRCT domain: structure, function, genetic mutations and links to diagnosis and treatment of breast and ovarian cancer. Pharmaceuticals. 2024;17(3):333.","journal-title":"Pharmaceuticals"},{"issue":"7","key":"5048_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/iub.472","volume":"63","author":"A Di Masi","year":"2011","unstructured":"Di Masi A, Gullotta F, Cappadonna V, Leboffe L, Ascenzi P. Cancer predisposing mutations in BRCT domains. IUBMB Life. 2011;63(7):503\u201312.","journal-title":"IUBMB Life"},{"issue":"3","key":"5048_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","volume":"16","author":"KE Baker","year":"2004","unstructured":"Baker KE, Parker R. Nonsense-mediated mRNA decay: terminating erroneous gene expression. Curr Opin Cell Biol. 2004;16(3):293\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"5048_CR37","first-page":"105","volume":"33","author":"G Khalili-Tanha","year":"2019","unstructured":"Khalili-Tanha G, Sebzari A, Moodi M, Hajipoor F, Naseri M. Mutations analysis of BRCA1 gene in patients with breast cancer in South Khorasan province, East Iran. Med J Islam Repub Iran. 2019;33:105.","journal-title":"Med J Islam Repub Iran"},{"issue":"5","key":"5048_CR38","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.21037\/tcr.2019.08.32","volume":"8","author":"T Wang","year":"2019","unstructured":"Wang T, Zhang J, Xiao J, Huang M, Li N, Ling R. Mutational analysis of BRCA1 and BRCA2 in northwest Chinese breast cancer patients. Transl Cancer Res. 2019;8(5):1845\u201352.","journal-title":"Transl Cancer Res"},{"issue":"7","key":"5048_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jmedgenet-2011-100674","volume":"49","author":"E Schulz","year":"2012","unstructured":"Schulz E, Valentin A, Ulz P, Beham-Schmid C, Lind K, Rupp V, et al. Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms. J Med Genet. 2012;49(7):422\u20138.","journal-title":"J Med Genet"},{"issue":"12","key":"5048_CR40","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1002\/ijc.22269","volume":"119","author":"MU Rashid","year":"2006","unstructured":"Rashid MU, Zaidi A, Torres D, Sultan F, Benner A, Naqvi B, et al. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer. 2006;119(12):2832\u20139.","journal-title":"Int J Cancer"},{"key":"5048_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/cancers6020771","volume":"6","author":"YW Yi","year":"2014","unstructured":"Yi YW, Kang H, Bae I. BRCA1 and oxidative stress. Cancers. 2014;6:771\u201395.","journal-title":"Cancers"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05048-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:48:11Z","timestamp":1776415691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-025-05048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5048"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05048-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the described experiments were conducted following Helsinki Convention 1992 guidelines. This study was approved by the Board of Studies (an IRB) of the Department of Biochemistry and Biotechnology, Institute of Biochemistry, Biotechnology, and Bioinformatics, The Islamia University of Bahawalpur. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not have any competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}